ArticleThoracic cancer2023

Clinicopathological impact of VEGFR2 and VEGF-C in patients with EGFR-major mutant NSCLC receiving osimertinib.

Kyoichi Kaira et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.